346 related articles for article (PubMed ID: 23879434)
21. Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.
Cariello R; Federico A; Sapone A; Tuccillo C; Scialdone VR; Tiso A; Miranda A; Portincasa P; Carbonara V; Palasciano G; Martorelli L; Esposito P; Cartenì M; Del Vecchio Blanco C; Loguercio C
Dig Liver Dis; 2010 Mar; 42(3):200-4. PubMed ID: 19502117
[TBL] [Abstract][Full Text] [Related]
22. [Physiopathology of bacterial translocation and spontaneous bacterial peritonitis in cirrhosis].
González Alonso R; González García M; Albillos Martínez A
Gastroenterol Hepatol; 2007 Feb; 30(2):78-84. PubMed ID: 17335715
[TBL] [Abstract][Full Text] [Related]
23. Role of intestinal function in cachexia.
Pirlich M; Norman K; Lochs H; Bauditz J
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):603-6. PubMed ID: 16912557
[TBL] [Abstract][Full Text] [Related]
24. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.
Muñoz L; Borrero MJ; Úbeda M; Conde E; Del Campo R; Rodríguez-Serrano M; Lario M; Sánchez-Díaz AM; Pastor O; Díaz D; García-Bermejo L; Monserrat J; Álvarez-Mon M; Albillos A
Hepatology; 2019 Sep; 70(3):925-938. PubMed ID: 30414342
[TBL] [Abstract][Full Text] [Related]
25. Allopurinol, oxidative stress and intestinal permeability in patients with cirrhosis: an open-label pilot study.
Spahr L; Bresson-Hadni S; Amann P; Kern I; Golaz O; Frossard JL; Hadengue A
Liver Int; 2007 Feb; 27(1):54-60. PubMed ID: 17241381
[TBL] [Abstract][Full Text] [Related]
26. The role of the gut barrier function in the pathophysiology of viral liver cirrhosis.
Choi Y; Jeon WK; Hwang SJ; Kim BI; Sohn CI; Park DI; Cho YK; Kim HJ; Park JH
Hepatogastroenterology; 2011; 58(109):1244-7. PubMed ID: 21937387
[TBL] [Abstract][Full Text] [Related]
27. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.
Seo YS; Shah VH
Clin Mol Hepatol; 2012 Dec; 18(4):337-46. PubMed ID: 23323248
[TBL] [Abstract][Full Text] [Related]
28. Intestinal paracellular permeability is not affected in chronic congestive heart failure.
Schaufelberger M; Ekman I; Björnsson E; Kalaitzakis E; Ekman T
Eur J Heart Fail; 2007; 9(6-7):574-8. PubMed ID: 17383229
[TBL] [Abstract][Full Text] [Related]
29. [Bacterial translocation in cirrhosis].
Bellot P; Francés R; Such J
Gastroenterol Hepatol; 2008 Oct; 31(8):508-14. PubMed ID: 18928751
[TBL] [Abstract][Full Text] [Related]
30. [Intestinal mucosal barrier dysfunction after abdominal operation and its clinical significance].
Zhang WB; Jiang HP
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):246-9. PubMed ID: 19246290
[TBL] [Abstract][Full Text] [Related]
31. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
Brun P; Castagliuolo I; Di Leo V; Buda A; Pinzani M; Palù G; Martines D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G518-25. PubMed ID: 17023554
[TBL] [Abstract][Full Text] [Related]
32. [Changes in mucosal and vascular bed in various parts of gastrointestinal tract in patients with liver cirrhosis with portal hypertension].
Sidorova IO
Eksp Klin Gastroenterol; 2012; (6):115-22. PubMed ID: 23402201
[No Abstract] [Full Text] [Related]
33. Bacterial translocation and its consequences in patients with cirrhosis.
Guarner C; Soriano G
Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):27-31. PubMed ID: 15647636
[TBL] [Abstract][Full Text] [Related]
34. Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.
Compare D; Coccoli P; Rocco A; Nardone OM; De Maria S; Cartenì M; Nardone G
Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):471-6. PubMed ID: 22546554
[TBL] [Abstract][Full Text] [Related]
35. Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice.
Zuo L; Li Y; Wang H; Wu R; Zhu W; Zhang W; Cao L; Gu L; Gong J; Li N; Li J
J Crohns Colitis; 2014 Dec; 8(12):1710-22. PubMed ID: 25205553
[TBL] [Abstract][Full Text] [Related]
36. Breaking bad - the two sides of gut microbiota in portal hypertension.
Mehta G; Mookerjee RP
Liver Int; 2014 Oct; 34(9):1295-7. PubMed ID: 24840789
[No Abstract] [Full Text] [Related]
37. Gastrointestinal dysfunction in liver cirrhosis.
Kalaitzakis E
World J Gastroenterol; 2014 Oct; 20(40):14686-95. PubMed ID: 25356031
[TBL] [Abstract][Full Text] [Related]
38. [The role of intestinal microflora in the development of complications of hepatic cirrhosis-associated portal hypertension].
Garbuzenko DV
Klin Med (Mosk); 2007; 85(8):15-9. PubMed ID: 17926483
[TBL] [Abstract][Full Text] [Related]
39. Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study.
Tandon P; Moncrief K; Madsen K; Arrieta MC; Owen RJ; Bain VG; Wong WW; Ma MM
Liver Int; 2009 Aug; 29(7):1110-5. PubMed ID: 19490420
[TBL] [Abstract][Full Text] [Related]
40. Intestinal mucosal alterations in rats with carbon tetrachloride-induced cirrhosis: changes in glycosylation and luminal bacteria.
Natarajan SK; Ramamoorthy P; Thomas S; Basivireddy J; Kang G; Ramachandran A; Pulimood AB; Balasubramanian KA
Hepatology; 2006 Apr; 43(4):837-46. PubMed ID: 16557555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
